European Archives - Page 453 of 1053 - European Medical Journal

Ripples of change in R&D

How can pharma companies improve inclusivity across their R&D cycles?

How Did Ultrasmall Bacteria Adapt to the Human Oral Microbiome?

Evidence has revealed how environmental bacteria have adapted to live inside humans as the oral microbiome…

Fungal Vaccines: Could Stem Cell Training Enhance Immune Response?

Research has demonstrated the potential of using a fungal vaccine to improve immune response to infections…

The Alternative: Ayahuasca

Jonathan continues his series on alternative medicine by escorting us to South America to learn about the hallucinogenic brew, ayahuasca.

EULAR 2021 Janssen-Sponsored symposium: “To see is to believe? Guidance on using imaging to optimize patient care in psoriatic arthritis”.

This podcast reviews presentations at EULAR focusing on the emerging role of X-ray, ultrasound, and MRI in the management of PsA in the clinical setting.

EULAR 2021 Janssen-Sponsored symposium: “The launching pad: exploring the potential of the IL-23 pathway in psoriatic arthritis.”

This episode highlights both the role of the IL-23 pathway in the pathogenesis of PsA and the potential IL-23 inhibitors hold for improving PsA outcomes.

Thyroid Papillary Carcinoma and Hyperthyroidism: A Case Study

Thyroid cancer is the most common malignant endocrine tumour in the world, but it only accounts for 1% of all cancers…

Novel Effective Treatment Approach to Graft-Versus-Host-Disease

Research has demonstrated that the use of dual cytokine blockers can mitigate toxic reactions, including graft-versus-host-disease…

Could a High-Fibre Diet Improve Responses to Cancer Treatment?

New research has revealed that a high-fibre diet has been linked to an increased progression-free survival (PFS) in patients with melanoma…

The 2022 Pharma Forecast

Join Marc and Helena in kicking off the new year with an episode predicting what 2022 has in store for pharma. Listen now!